15.05.2014 NEXUS AG  DE0005220909

DGAP-Adhoc: NEXUS AG: SUBSTANTIAL INCREASE IN SALES AND RESULT IN THE FIRST QUARTER 2014


 
NEXUS AG / Key word(s): Quarter Results 15.05.2014 08:41 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Villingen-Schwenningen, 15 May 2014 Nexus AG, specialized in hospital software, was able to increase sales by 12% and its result before taxes by 13% in the first quarter 2014. As a result, its long-lasting growth phase could be continued further. Sales increased from KEUR 16,604 (Q1 2013) to KEUR 18,596 in the fi rst quarter 2014 (+12.0%). The result before taxes improved from KEUR 1,662 to KEUR 1,878 (+13.0%). The sales increase in the Healthcare Software Division was 14.8% and amounted to KEUR 16,652 following KEUR 14,509 in the previous year. Sales decreased by 7% in the Healthcare Service segment in the fi rst quarter. The area recorded sales of KEUR 1,944 following KEUR 2,095 in the fi rst quarter 2013. The international share of total business volume was 45.9% (previous year: 42.9%). The result before taxes improved by 6.0% to KEUR 1,806 compared to the same period of the previous year (Q1 2013: KEUR 1,702). The EBITDA increased by approx. 6.8% to KEUR 3,460 (Q1 2013: KEUR 3,240) during the reporting period. The cash flow in the first quarter developed especially strongly. The cash flow from current business transactions reached KEUR 8,164 and consequently considerably surpassed the high value of the previous year of KEUR 4,547 (+79.5%). Liquid funds developed correspondingly. They increased by approx. KEUR 6,148 to KEUR 29,952 million compared to the end of the business year (31 December 2013: KEUR 23,804). NEXUS AG has equity capital amounting to KEUR 74,270. As a result, NEXUS AG has a sustainable healthy balance sheet and suffi cient capital for financing further growth. --------------------------------------------------------------------------- Information and Explaination of the Issuer to this News: NEXUS AG - the e-health specialist - develops and sells IT solutions for healthcare systems. These solutions make it possible for hospitals, senior citizen homes, rehabilitation and welfare institutions to convert to digital patient information. NEXUS also supports integrated healthcare, which enables data exchange between primary care physicians, hospitals and rehabilitation clinics. More than 650 staff members in the NEXUS-group develop software solutions for the healthcare sector, with which approximately 180,320 users in 25 countries work worldwide on a daily basis. 15.05.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: NEXUS AG Auf der Steig 6 78052 Villingen-Schwenningen Germany Phone: +49 (0)7721 8482-0 Fax: +49 (0)7721 8482-311 E-mail: [email protected] Internet: www.nexus-ag.de ISIN: DE0005220909 WKN: 522090 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------


Die wichtigsten Finanzdaten auf einen Blick
  2015 2016 2017 2018 2019 2020 2021e
Umsatzerlöse1 97,27 107,05 119,08 136,47 147,65 162,94 169,00
EBITDA1,2 18,88 21,02 23,72 26,71 33,95 36,64 39,50
EBITDA-Marge3 19,41 19,64 19,92 19,57 22,99 22,49 23,37
EBIT1,4 9,64 10,93 13,32 15,18 17,44 19,92 22,90
EBIT-Marge5 9,91 10,21 11,19 11,12 11,81 12,23 13,55
Jahresüberschuss1 9,64 8,61 10,16 11,00 12,12 15,09 18,10
Netto-Marge6 9,91 8,04 8,53 8,06 8,21 9,26 10,71
Cashflow1,7 18,15 16,54 21,68 20,24 24,62 30,95 29,50
Ergebnis je Aktie8 0,48 0,52 0,62 0,69 0,69 0,96 1,23
Dividende8 0,14 0,15 0,16 0,17 0,18 0,19 0,21
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2020 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Ebner Stolz

INVESTOR-INFORMATIONEN
©boersengefluester.de
Nexus
WKN Kurs in € Einschätzung Börsenwert in Mio. €
522090 72,900 Kaufen 1.148,34
KGV 2022e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
54,40 31,33 1,74 111,13
KBV KCV KUV EV/EBITDA
9,38 37,11 7,05 31,79
Dividende '19 in € Dividende '20e in € Div.-Rendite '20e
in %
Hauptversammlung
0,18 0,19 0,26 27.04.2021
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
11.05.2021 10.08.2021 09.11.2021 09.03.2021
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
4,52% 17,88% 42,94% 62,00%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu NEXUS AG  ISIN: DE0005220909 können Sie bei DGAP abrufen

Software , 522090 , NXU , XETR:NXU